| |
|
|
BOARD OF DIRECTORS
| Martin
Greenberger, PhD
|
Professor
and IBM Chair in Technology & Information Systems, The
University of California at Los Angeles |
| Eugene
W. Nester, PhD
|
Member
of the National Academy of Sciences and Professor of Microbiology
at The University
of Washington, Seattle |
|
|
|
| Lee
A. Bulla, Jr., PhD
|
| Dr.
Lee A. Bulla founded Biological Targets Inc. and has served as
president and chief executive officer since BTI's inception in
1999. Dr. Bulla has more than 30 years in biological scientific
research and administration. He is Professor of Molecular Biology
and Director of the Center for Biotechnology & Bioinformatics,
a research and technology development center that is organized
to integrate applications in biology, chemistry, physics and computer
sciences at The University of Texas at Dallas.
Dr.
Bulla also holds a faculty appointment in the Joint Program in
Biomedical Engineering at The University of Texas Southwestern
Medical Center in Dallas. Prior to his joining the faculty of
The University of Texas, he served as Dean of the College of Agriculture
and Chairman of the Department of Molecular Biology at The University
of Wyoming. The foundation of Dr. Bulla’s research is based on
the bacterium Bacillus thuringiensis and its insecticidal Cry
proteins. In addition to his academic career, Dr. Bulla is a co-founder
and Chairman of BioGro International , headquartered in Giza ,
Egypt , a company that has successfully developed a commercial
Bt biopesticide for agricultural crops. Dr. Bulla holds a PhD
in Microbiology from Oregon State University with specialties
in Biochemistry and Cell Biology. He has extensive knowledge and
research experience in the fields of soil microbiology and bacterial
pathogen-insect relationships. Dr. Bulla has administered government,
academic and industrial grants exceeding $30M in conjunction to
various projects that have resulted in numerous scientific publications.
|
 |
|
| Martin Greenberger,
PhD
|
| Dr.
Martin Greenberger has held the IBM chair in technology and information
systems at the UCLA Anderson School of Management since 1982.
He is also senior fellow at the Milken Institute and president
of Council for Technology and the Individual, a nonprofit foundation
dealing with the human dimensions of technology. Before
joining UCLA, Dr. Greenberger served at Johns Hopkins University
as chairman of the PhD program in computer science, director of
information processing, and professor of mathematical sciences.
He currently teaches graduate courses at UCLA on Frontiers in
Biotechnology and Investing in Health.
Dr.
Greenberger received AB, AM, and PhD degrees in applied mathematics
and economics from Harvard University. |
|
|
|
| Emanuel
S. Hellman, MD |
| Dr.
Hellman received his AB in engineering sciences and applied physics
from Harvard in 1953 and MD from Harvard Medical School in 1957.
His medical career has included bench and medical research on
acute intermittent porphyria at the National Institutes of Health
and teaching and administration as a clinical assistant professor
of medicine at Harvard Medical School until 1972 when he moved
to Tucson, Arizona. Until retirement in July, 2005, Dr.
Hellman's focus has been the primary practice of internal medicine
with international consultation and teaching in Peru, Kazakhstan,
Turkmenistan and China. |
|
|
|
| Kary
B. Mullis, PhD |
|
Dr.
Mullis received the Nobel Prize in Chemistry in 1993 for his invention
of the polymerase chain reaction (PCR). The process, which Dr.
Mullis conceptualized in 1983, is hailed as one of the monumental
scientific techniques of the twentieth century. Dr. Mullis received
a BS Chemistry from the Georgia Institute of Technology in 1966.
He earned a PhD degree in Biochemistry from The University of
California at Berkeley in 1972 and lectured in biochemistry there
until 1973. In 1986, he was named Director of Molecular Biology
at Xytronyx, Inc. in San Diego, where his work was concentrated
in DNA technology and photochemistry. In 1987 he began consulting
on nucleic acid chemistry for more than a dozen corporations,
including Angenics, Cytometrics, Eastman Kodak, Abbott Labs and
Milligen/Biosearch and Specialty Laboratories. Dr.
Mullis serves on the board of scientific advisors of several companies,
provides expert advice in legal matters involving DNA, and is
a frequent lecturer at college campuses, corporations and academic
meetings around the world. |
| |
|
| Eugene
W. Nester, PhD |
| Dr.
Nester was elected to the National Academy of Sciences in 1994
for his pioneering work on the soil microorganism Agrobacterium
tumefaciens, which transfers a small piece of a tumor-inducing
(Ti) plasmid (T-DNA) into plant cells where it becomes integrated
into the plant chromosome and confers new properties on the tissue.
Agrobacterium currently is used worldwide to genetically
engineer plants. Dr.
Nester was educated at Cornell University and Case Western Reserve
University and did postgraduate work at Stanford University. He
has received a number of awards for his research including the
inaugural Australia Prize (1990) and the Cetus Award in Biotechnology
(1991). He is a member of the editorial board of CRC
Critical Reviews in Plant Science and Molecular Plant
Microbe Interactions. He is the co-author of three
textbooks, the most recent Microbiology, A Human Perspective.
He currently is Chair of the Board of Governors of the American
Academy of Microbiology and a member of the National Academy of
India. |
|
|
| Timothy
R. Vaughan, Esq.
|
Mr.
Vaughan receive a BS degree (magna cum laude) from Washington
& Lee University and his law degree (with honors) from The
University of Texas at Austin. He has experience with public
offerings and private issuances of securities, mergers and acquisitions,
private equity investments, federal securities law compliance,
contract negotiations and the representation of bank lenders in
commercial loan transactions. He has particular expertise resulting
from his representation of venture capital and private equity
investors, as well as entrepreneurs, within the construction,
technology, software, oil and gas, retail and manufacturing industries.
Mr. Vaughan has also served as issuer counsel in numerous underwritten
public offerings within the property and casualty insurance, retail,
manufacturing and software industries. |
|
|
|
| Daneil
M. Norton, MBA |
| Mr.
Norton owns and manages Norton Investments (Colorado Springs, CO),
a private investment and consulting firm serving private investors
and non-profit organizations. Mr. Norton has BA degree in business
and economics from Colorado College and MBA from The University
of Denver. He is a CPA and CFA. |
|
|
|
|
